Latest statistics and disclosures from Abingworth's latest quarterly 13F-HR filing:
- Top 5 stock holdings are Prosensa Hldgs B V Shs Usd, Lombard Med, Supernus Pharmaceuticals, Portola Pharmaceuticals, Dicerna Pharmaceuticals. These five stock positions account for 84.67% of Abingworth's total stock portfolio.
- Added to shares of these 3 stocks: Lombard Med (+$25.65M), Anthera Pharmaceutcls, Epirus Biopharmaceuticals In.
- Started 3 new stock positions in Anthera Pharmaceutcls, Lombard Med, Epirus Biopharmaceuticals In.
- Reduced shares in these 5 stocks: Portola Pharmaceuticals (-$7.84M), Supernus Pharmaceuticals (-$6.26M), Gw Pharmaceuticals Plc ads (-$6.07M), , .
- Sold out of its positions in Anthera Pharmaceuticals, Gw Pharmaceuticals Plc ads, ZLCS.
- As of Sept. 30, 2014, Abingworth has $167.25M in assets under management (AUM). Assets under management dropped from a total value of $181.25M to $167.25M.
- Independent of market fluctuations, Abingworth was a net buyer by $4.80M worth of stocks in the most recent quarter.
Abingworth portfolio companies for September 2014 quarter
|Ticker||Name||Portfolio Weight||Change||Share Count||Price||Last Trade|
|Prosensa Hldgs B V Shs Usd||31.32||6213924||8.43||0.00|
|Epirus Biopharmaceuticals In||0.03||NEW||7896||7.09||0.00|
Past 13F-HR SEC Filings for Abingworth
- Abingworth 2014 Q1 - filed May 21, 2014
- Abingworth 2013 Q2 - filed Aug. 14, 2013
- Abingworth 2013 Q1 - filed May 15, 2013
- Abingworth 2012 Q4 - filed Feb. 13, 2013
- Abingworth 2012 Q3 - filed Nov. 7, 2012
- Abingworth 2012 Q1 - filed May 14, 2012
- Abingworth 2011 Q4 - filed Feb. 7, 2012
- Abingworth 2011 Q3 - filed Nov. 14, 2011
- Abingworth 2011 Q1 - filed May 13, 2011
- Abingworth 2010 Q4 - filed Feb. 14, 2011